His Thyroid investigation overlaps with other areas such as Thyroid cancer and Thyroidectomy. In his research, he undertakes multidisciplinary study on Thyroid cancer and Thyroid. His Internal medicine study frequently draws connections to other fields, such as Neck dissection. He integrates many fields, such as Cancer and Pathology, in his works. Ian Ganly applies his multidisciplinary studies on Pathology and Cancer in his research. His study deals with a combination of Oncology and Gastroenterology. Gastroenterology and Oncology are two areas of study in which he engages in interdisciplinary work. He merges Surgery with Radiation therapy in his study. In his research, Ian Ganly undertakes multidisciplinary study on Radiation therapy and Surgery.
His study on Surgery is mostly dedicated to connecting different topics, such as Radiation therapy, Retrospective cohort study and Head and neck cancer. Ian Ganly conducts interdisciplinary study in the fields of Radiation therapy and Surgery through his research. In his study, he carries out multidisciplinary Internal medicine and Gastroenterology research. Ian Ganly undertakes interdisciplinary study in the fields of Cancer and Gene through his works. With his scientific publications, his incorporates both Gene and Cancer. In his works, he performs multidisciplinary study on Oncology and Pathology. By researching both Pathology and Oncology, Ian Ganly produces research that crosses academic boundaries. His study ties his expertise on Thyroid carcinoma together with the subject of Thyroid. His Thyroid carcinoma study frequently involves adjacent topics like Thyroid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally.
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
Fadlo R. Khuri;John Nemunaitis;Ian Ganly;James Arseneau.
Nature Medicine (2000)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa;Tihana Ibrahimpasic;Laura Boucai;Rileen Sinha.
Journal of Clinical Investigation (2016)
Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer
J. Nemunaitis;F. Khuri;I. Ganly;J. Arseneau.
Journal of Clinical Oncology (2001)
A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
Ian Ganly;Ian Ganly;David Kirn;Susan G. Eckhardt;Gail I. Rodriguez.
Clinical Cancer Research (2000)
Selective Replication and Oncolysis in p53 Mutant Tumors with ONYX-015, an E1B-55kD Gene-deleted Adenovirus, in Patients with Advanced Head and Neck Cancer: A Phase II Trial
John Nemunaitis;Ian Ganly;Fadlo Khuri;James Arseneau.
Cancer Research (2000)
The head and neck cancer immune landscape and its immunotherapeutic implications.
Rajarsi Mandal;Yasin Şenbabaoğlu;Alexis Desrichard;Jonathan J. Havel.
JCI insight (2016)
The Mutational Landscape of Adenoid Cystic Carcinoma
Allen S Ho;Kasthuri Kannan;David M Roy;Luc G T Morris.
Nature Genetics (2013)
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
Iñigo Landa;Ian Ganly;Timothy A. Chan;Norisato Mitsutake.
The Journal of Clinical Endocrinology and Metabolism (2013)
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
Luc G T Morris;Andrew M Kaufman;Yongxing Gong;Deepa Ramaswami.
Nature Genetics (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: